ACEi and ARBS in Hypertension and Heart Failure

Häftad, Engelska, 2014

Del 5 i serien Current Cardiovascular Therapy

496 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function.

Produktinformation

Utgivningsdatum:2014-11-03
Mått:127 x 203 x 9 mm
Vikt:186 g
Format:Häftad
Språk:Engelska
Serie:Current Cardiovascular Therapy
Antal sidor:150
Förlag:Springer International Publishing AG
ISBN:9783319097879

Utforska kategorier

Farmakologi inom Medicin
Hjärt- och kärlsjukdomar inom Medicin

Mer om författaren

Pasquale Ferrone Filardi is an Associate Professor of Cardiology and head of the Cardiology School at the University of Naples, Italy.

Innehållsförteckning

Pathogenetic mechanisms of RAS involvement in cardiovascular diseases.- Antiotensin converting enzyme inhibitors and at1 antagonists for treatment of hypertension.- Renin angiotensin system antagonism in heart failure.- Impact of co-morbidities on RAS inhibitors choice in hypertensive and heart failure patients.- Target organ damage and RAS blockade.